Form 8-K - Current report:
SEC Accession No. 0001437749-22-024955
Filing Date
2022-10-27
Accepted
2022-10-27 16:34:05
Documents
14
Period of Report
2022-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lmat20221027_8k.htm   iXBRL 8-K 37513
2 EXHIBIT 99.1 ex_438244.htm EX-99.1 343699
  Complete submission text file 0001437749-22-024955.txt   533842

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lmat-20221027.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lmat-20221027_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lmat-20221027_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lmat-20221027_pre.xml EX-101.PRE 11689
8 EXTRACTED XBRL INSTANCE DOCUMENT lmat20221027_8k_htm.xml XML 2551
Mailing Address 63 SECOND AVENUE BURLINGTON MA 01803
Business Address 63 SECOND AVENUE BURLINGTON MA 01803 781-221-2266
LEMAITRE VASCULAR INC (Filer) CIK: 0001158895 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33092 | Film No.: 221337762
SIC: 3841 Surgical & Medical Instruments & Apparatus